Clinical Trial Update: LEPR Polymorphism Weight Gain by Mirtazapine in Late Life Depression [Phase 4]

View source ↗

Summary

This document provides a Phase 4 clinical trial update on weight gain associated with LEPR polymorphism in late-life depression treated with mirtazapine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• mirtazapine (mirtazapine)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED